MIM
HALO icon

Macroview Investment Management’s Halozyme HALO Stock Holding History

Macroview Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-204
Closed -$3K – 327
2019
Q1 		$3K Buy
+204
New +$3.31K 0.01% 245

Other funds holding HALO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Macroview Investment Management's HALO Position: Q2 2019 in Review

Macroview Investment Management sold out of Halozyme (HALO) in Q2 2019, closing a stake of 204 shares — an estimated $3K sold.

Macroview Investment Management first reported a position in HALO in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

  • Macroview Investment Management reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
  • Macroview Investment Management sold 204 Halozyme shares in Q2 2019, an estimated $3K.
  • Macroview Investment Management first reported a position in Halozyme in Q1 2019 and held it in 1 quarter.
  • Macroview Investment Management's Halozyme position peaked at $3K in Q1 2019.
  • 202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on Macroview Investment Management's 13F filing for Q2 2019, filed 23 Jul 2019.